Click here for free access to our latest coronavirus/COVID-19 research, commentary, and news.

Support nonprofit science journalism

Science’s extensive COVID-19 coverage is free to all readers. To support our nonprofit science journalism, please make a tax-deductible gift today.

Donate

Not Now

Jop de Vrieze

Jop de Vrieze is a science journalist in Amsterdam.

Jop de Vrieze

Jop de Vrieze is a science journalist in Amsterdam.

Latest Stories

Can a century-old TB vaccine steel the immune system against the new coronavirus?

By Jop de VriezeMar. 23, 2020
A shot of hope

By Jop de VriezeNov. 29, 2019
First malaria vaccine rolled out in Africa—despite limited efficacy and nagging safety concerns

By Jop de VriezeNov. 26, 2019
The metawars

By Jop de VriezeSep. 21, 2018
Podcast: Do scientists make great contributions after 30? We chat with experts about some common scientific myths

By Sarah Crespi, Jop de VriezeSep. 20, 2018
Meta-analyses were supposed to end scientific debates. Often, they only cause more controversy

By Jop de VriezeSep. 18, 2018
Open-access journal editors resign after alleged pressure to publish mediocre papers

By Jop de VriezeSep. 4, 2018
Trials of impotence drug to help poorly growing fetuses are halted after infant deaths

By Jop de VriezeJul. 25, 2018
Scientists beware: The price is high, the payoff uncertain at glossy publications aimed at Europe’s decision-makers

By Jop de VriezeMar. 14, 2018
This new index ranks companies’ efforts in the fight against antimicrobial resistance

By Jop de VriezeJan. 23, 2018
Nearly 100 scientists spent 2 months on Google Docs to redefine the p-value. Here’s what they came up with

By Jop de VriezeJan. 18, 2018
‘Science wars’ veteran has a new mission

By Jop de VriezeOct. 13, 2017
Bruno Latour, a veteran of the ‘science wars,’ has a new mission

By Jop de VriezeOct. 10, 2017
Funders groan under growing review burden

By Jop de VriezeJul. 28, 2017
‘Replication grants’ will allow researchers to repeat nine influential studies that still raise questions

By Jop de VriezeJul. 11, 2017
What watching Star Trek can teach you about scientific integrity

By Jop de VriezeJun. 1, 2017

Support nonprofit science journalism

Jop de Vrieze

Jop de Vrieze

Latest Stories

Can a century-old TB vaccine steel the immune system against the new coronavirus?

A shot of hope

First malaria vaccine rolled out in Africa—despite limited efficacy and nagging safety concerns

The metawars

Podcast: Do scientists make great contributions after 30? We chat with experts about some common scientific myths

Meta-analyses were supposed to end scientific debates. Often, they only cause more controversy

Open-access journal editors resign after alleged pressure to publish mediocre papers

Trials of impotence drug to help poorly growing fetuses are halted after infant deaths

Scientists beware: The price is high, the payoff uncertain at glossy publications aimed at Europe’s decision-makers

This new index ranks companies’ efforts in the fight against antimicrobial resistance

Nearly 100 scientists spent 2 months on Google Docs to redefine the p-value. Here’s what they came up with

‘Science wars’ veteran has a new mission

Bruno Latour, a veteran of the ‘science wars,’ has a new mission

Funders groan under growing review burden

‘Replication grants’ will allow researchers to repeat nine influential studies that still raise questions

What watching Star Trek can teach you about scientific integrity

Latest News

Staff Writers

Support nonprofit science journalism

Jop de Vrieze

Jop de Vrieze

Latest Stories

Latest News

Staff Writers

Read the Latest Issue of Science

27 March 2020

Scientific Community

Ecology

Asia/Pacific News

Epidemiology

Medicine/Diseases

Medicine/Diseases